US$ 21.43
retatrutide type 2 diabetes trial results 2024 2025 ๐ A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with diabetes, a new phase 3 shows. is part of an emerging generation Retatrutide Phase 3 Updates: Significant
Description
GLP-1 plays a crucial role in regulating blood sugar levels and promoting satiety
Is the Wegovy pill the same as Rybelsus
A year later, those on the medication lost about 8 percent of their weight

In a subgroup of participants with BMI of 35 kg/m 2 , high doses of 8 and 12 mg of retatrutide effected a 26.5% weight loss over 48 weeks compared to those categorized with BMI 5%, as compared to 27% in the placebo group

The consistency of these improvements across study visits suggested sustained metabolic benefit rather than temporary fluctuations